KRAS and cancer: We further investigated the uptake of RBCEVs loaded with Alexa Fluor 488 (AF488)-labeled ASO by mutated KRAS-harboring cancer cells, including A427 cells (KRAS G12D) and H441 cells (KRAS G12V) (Figure S3A), using flow cytometry.